Fact CheckerSign in

NCT04566731Completed

Treating Primary Progressive Aphasia (PPA) Using tDCS

Using Transcranial Direct Current Stimulation to Reveal Mechanisms of Language Loss and to Treat Progressive Aphasia Associated With FTD and Related Dementias

Source: ClinicalTrials.gov · Last updated 13 Nov 2025

Brief summary (registry, in English)

This is a double-blind, sham-controlled, crossover study in which subjects with the non-fluent/agrammatic and semantic variants of primary progressive aphasia (naPPA and svPPA, respectively) will undergo language testing and structural and functional brain imaging before and after receiving 10 semi-consecutive daily sessions of real or sham transcranial direct current stimulation (tDCS) paired with modified constraint-induced language therapy (mCILT). Language testing and brain imaging will be repeated immediately after completion of and up-to 24 weeks following completion of treatment. The investigators will examine changes in language performance induced by tDCS + mCILT compared to sham tDCS + mCILT. The investigators will also use network science to analyze brain imaging (fMRI) data to identify network properties associated with baseline PPA severity and tDCS-induced changes in performance. This study will combine knowledge gained from our behavioral, imaging, and network data in order to determine the relative degrees to which these properties predict whether persons with PPA will respond to intervention.

Status (registry)
Completed
Study type
Interventional
Enrollment
23 (actual)
First submitted
31 Aug 2020
Start date
1 Dec 2020
Primary completion date
1 Jul 2024
Lead sponsor
University of Pennsylvania
NCT number
NCT04566731

What you commit to

  • Study type: Interventional
  • Participants enrolled: 23
  • From 1 Dec 2020 to the primary completion date, 1 Jul 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Subjects with metallic objects in the face or head other than dental apparatus such as braces, fillings, and implants.
  • Subjects with previous craniotomy or any breach in the skull

Other illness

  • History of seizures or unexplained loss of consciousness
  • Subjects with a history of other neurological disorder (stroke, TBI, Parkinson)
  • Subjects with a history of small vessel disease

Other

  • Subjects with Pacemakers or ICDs.

Who the study is looking for

  • Presence of aphasia attributable to the semantic variant (svPPA) or non- fluent/agrammatic variant (naPPA) of Primary Progressive Aphasia.
  • Must be a native English speaker

Age in the registry: 45 years to 80 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
University of Pennsylvania
Coordinator of this site? Confirm its status
PhiladelphiaUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.